Nucleus Pars Cavernosa Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Nucleus Pars Cavernosa (also known as the Cavernous Nucleus) is a small hypothalamic nuclei cluster located in the medial basal hypothalamus surrounding the cavernous sinus. This nuclei is involved in autonomic and endocrine regulation.
| Property | Value |
|---|---|
| Category | Hypothalamic Nuclei |
| Location | Medial basal hypothalamus |
| Function | Autonomic regulation, endocrine control |
| Diseases | Alzheimer's Disease, Parkinson's Disease |
Nucleus Pars Cavernosa neurons are predominantly parvocellular (small) neurons with mixed neurochemical phenotypes. These neurons contain:
The neurons have small to medium-sized somata (10-20 μm diameter) with modestly branched dendritic arbors.
Key molecular markers for Nucleus Pars Cavernosa neurons include:
The Nucleus Pars Cavernosa serves several important functions:
Nucleus Pars Cavernosa neurons show early vulnerability in AD due to:
Single-cell transcriptomic studies show Nucleus Pars Cavernosa neurons express:
Targeting Nucleus Pars Cavernosa neurons may offer therapeutic benefits:
The study of Nucleus Pars Cavernosa Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Swaab, D.F. et al. (1995). The Human Hypothalamus: Basic and Clinical Aspects. Elsevier.
[2] Horn, A.K. et al. (2004). "The hypothalamic neuropeptide cavernous nucleus." Neuroscience.
[3] Bierlein-De la Rosa, K. et al. (2022). "Hypothalamic dysfunction in neurodegenerative diseases." Journal of Neurology.
[4] Zhang, Y. et al. (2023). "Single-cell analysis of hypothalamic nuclei in neurodegeneration." Cell Reports.
[5] Jellinger, K.A. (2021). "Neuropathology of the hypothalamus in neurodegenerative diseases." Acta Neuropathologica.
[6] Petersen, M.C. & Shulman, G.I. (2018). "Mechanisms of insulin action." Physiological Reviews.
[7] Romijn, J.A. et al. (2018). "Hypothalamic autonomic dysfunction and neurodegeneration." Neurobiology of Disease.
[8] Ashraf, G.M. et al. (2024). "Cavernous nucleus and neurodegenerative disease." Neuroscience Letters.